Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Chicago Crusader, The American Journal of Managed Care® (AJMC®), Pluang and Modern Healthcare. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 8h ago.
Quick answers
Why is "Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare covera" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Medicare Spurs 700K Seniors to GLP-1s; Lilly Leads Briefs Finance · 13h ago
- State Medicaid program will now cover GLP-1 weight loss drugs The Chicago Crusader · 13h ago
- Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD The American Journal of Managed Care® (AJMC®) · 13h ago
- 700,000 seniors start GLP-1 obesity treatments under Medicare, 70% choose Eli Lilly drugs Pluang · 13h ago
- Medicare GLP-1 Bridge program a potential headwind for insurers Modern Healthcare · 13h ago
- Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs CNBC · 13h ago
Topics
Related trends
GameStop CEO Ryan Cohen Buys Another $26 Million of GME Stock
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly is breaking ground in Houston on a facility planned for 2030
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Watch Snap's CEO Demo Specs True AR Glasses Live On Stage
2 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
Novo Nordisk shares slide despite aggressive obesity targets as investors demand a broader long-term strategy.